🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients

RecruitingNAAges 18 Years - anyAllCentre Hospitalier Annecy Genevois
NCT07651436 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Hemodialysis is a vital replacement therapy for patients with end-stage chronic kidney disease, but it imposes a heavy, demanding, and prolonged management, associated with a significant deterioration in quality of life. Hemodialysis patients are exposed to numerous physical, organizational, and social constraints, including repeated and prolonged sessions at the center, dietary and fluid restrictions, chronic fatigue, and frequent comorbidities. Therefore, depressive disorders in hemodialysis patients represent a major public health issue. The literature reports a high prevalence of depressive symptoms among hemodialysis patients, ranging from 22% to 60%, significantly higher than that observed in the general population. These disorders are associated with a significant deterioration in quality of life, increased hospitalizations, lower therapeutic adherence, an increased risk of suici

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient informed about the nature, process, and objectives of the study and having signed a free and informed consent to participate, * Patient treated with conventional hemodialysis for at least 3 months and currently undergoing dialysis 3 times a week, * Patient covered by the french national social welfare Exclusion Criteria: * Patient suffering from dementia * Pregnant or breastfeeding patient * Patient unable to understand the French language both orally and in writing, - making self-assessment impossible * Patient currently participating in another interventional research protocol or in an exclusion period from such research * Patient who has already been included in this study * Patient under guardianship, curatorship, or placed under judicial protection.
💊

What it tests

  • evaluate the psychometric performance of different modalities of hetero-assessment of depressive symptoms by nurses
📍

Where

2 sites
Centre Hospitalier Annecy Genevois
Annecy, France
Centre Hospitalier Métropole Savoie
Chambéry, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy